Darunavir Tacrolimus 1002

Prezista label

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 1 effect

Not studied

Drug 2
Drug 2 effect

Not studied (may increase tacrolimus levels)

Clinical Effects

Potential for increased risk of tacrolimus adverse effects

Management

If coadministering, consider initiating lower immunosuppressant dose. Therapeutic drug monitoring is recommended. Consult with specialist as necessary.

Import ID
1002